Earnings Feed
Start Free
Home/Filings/4/0001209191-16-103390
4//SEC Filing

EnteroMedics Inc 4

Accession 0001209191-16-103390

CIK 0001371217operating
View on SEC.govCompany Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 4:30 PM ET

Size

26.1 KB

Accession

0001209191-16-103390

Insider Transaction Report

Form 4
Period: 2016-02-25
EnteroMedics IncETRM
KNUDSON MARK B
DirectorChrmn, Pres & CEO
Transactions
  • Award

    Director Option (right to buy)

    2016-02-25+3,333→ 3,333 total
    Exercise: $1.07From: 2016-02-25Exp: 2026-02-25→ Common Stock (3,333 underlying)
Holdings

  • Common Stock

    (indirect: By Trust)
    93

  • Common Stock

    (indirect: By Partnership)
    215

  • Common Stock

    (indirect: By Trust)
    3,838

  • Common Stock

    40,867

  • Stock Option (right to buy)

    Exercise: $41.40Exp: 2016-04-20→ Common Stock (451 underlying)
    451

  • Stock Option (right to buy)

    Exercise: $28.50Exp: 2017-10-29→ Common Stock (2,228 underlying)
    2,228

  • Stock Option (right to buy)

    Exercise: $28.50Exp: 2017-10-29→ Common Stock (1,726 underlying)
    1,726

  • Stock Option (right to buy)

    Exercise: $28.50Exp: 2017-10-29→ Common stock (2,942 underlying)
    2,942

  • Stock Option (right to buy)

    Exercise: $28.50Exp: 2017-10-29→ Common Stock (3,364 underlying)
    3,364

  • Stock Option (right to buy)

    Exercise: $56.70Exp: 2018-12-31→ Common Stock (1,388 underlying)
    1,388

  • Warrant (common stock right to buy)

    Exercise: $32.85→ Common Stock (1,666 underlying)
    1,666

  • Stock Option (right to buy)

    Exercise: $38.70Exp: 2018-12-31→ Common Stock (23,333 underlying)
    23,333

  • Stock Option (right to buy)

    Exercise: $40.05Exp: 2018-12-31→ Common Stock (23,333 underlying)
    23,333

  • Stock Option (right to buy)

    Exercise: $28.50Exp: 2018-12-31→ Common Stock (13,333 underlying)
    13,333

  • Stock Option (right to buy)

    Exercise: $50.25Exp: 2018-12-31→ Common Stock (86,148 underlying)
    86,148

  • Stock Option (right to buy)

    Exercise: $19.65Exp: 2018-12-31→ Common Stock (85,248 underlying)
    85,248

  • Stock Option (right to buy)

    Exercise: $16.65Exp: 2018-12-31→ Common Stock (15,000 underlying)
    15,000
Footnotes (5)
  • [F1]On January 6, 2016, EnteroMedics Inc. effected a 1-for-15 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person. all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
  • [F2]Options currently 100% vested.
  • [F3]Warrant becomes exercisable 181 days from the date of issuance at close of offering.
  • [F4]Warrant expires five years from the date it becomes exercisable.
  • [F5]Vests immediately as to 25% on date noted and thereafter in cumulative installments of 1/36th per month.

Documents

1 file

Issuer

EnteroMedics Inc

CIK 0001371217

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001371217

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:30 PM ET
Size
26.1 KB
View on SEC.gov